Neurogen-Pfizer Keeps on Ticking
Executive Summary
The Pfizer-Neurogen research collaboration has thrived largely because of the coalescence of unique factors--geographic proximity, a particularly close working relationship and a pre-proven therapeutic mechanism--that will be hard to replicate. Indeed , in light of the current biotech funding environment, it is unlikely that a company like Neurogen would even get off the ground today.